跳至主要内容
临床试验/IRCT20240323061353N1
IRCT20240323061353N1招募中3 期

Effect of Pentoxifylline in improvement Myocardial Injury in Patients with ST-elevation myocardial infarction treated by primary percutaneous coronary intervention

Bagheiat-allah University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Diagnosis of STEMI, as chest pain lasting more than 30 minutes and less than 12 hours with ST-segment elevation at the J point on the ECG for more than 1 mm in at least two consecutive leads
  • Precancerous coronary intervention successful
  • sinus rhythm
  • Informed consent to participate in the study

排除标准

  • Recent history (within 3 months) of coronary artery bypass grafting
  • Receive thrombolytic therapy
  • Recent electrophysiological interventions of the heart
  • Cardiogenic shock at the time of presentation
  • History of kidney failure (Creatinine > 2.5 mg/dL)
  • Allergy and contraindication to aspirin, clopidogrel or pentoxifylline
  • Those who are pregnant or breastfeeding
  • Dissatisfaction and those who want to stop the study at any time

研究者

发起方
Bagheiat-allah University of Medical Sciences

相似试验